CD8A and neoplasm: The binding of OX40L to OX40 on the surface of activated T cells significantly enhanced the proliferation and survival of CD4+ and CD8+ T cells and the secretion of IFN-γ and IL-2, while inhibiting the immunosuppressive activity of regulatory T cells, thereby amplifying the anti-tumor immunity.